Liquid biopsy is a new, minimally invasive technology for detection of disease biomarkers without the need for costly or invasive procedures. In this video, Dr. Brian Adams talks about the role of miRNA from exosomes as potential circulating biomarkers, challenges and recommended techniques for isolating these tiny microvesicles. Liquid biopsies promise to revolutionize the way serious diseases are detected and monitored.
August 23, 2019
July 11, 2019
Clinical Workﬂow for Identiﬁcation of Novel Primary Graft Dysfunction Biomarkers using Exosome Proteomics
June 4, 2019
May 28, 2019